Why the study?
Although the polygenic risk score (PRS) is seen as advantageous for predicting complex disease risk, a systematic evaluation of its influence on outcomes and predictive value was needed.
Does the polygenic risk score (PRS) improve the prediction accuracy for the incidence risk of 32 complex diseases compared to traditional clinical risk tools?
Does the polygenic risk score (PRS) improve the prediction accuracy for the incidence risk of 32 complex diseases compared to traditional clinical risk tools?
Answers are grounded in this paper and cite their sources.
Polygenic risk scores can enhance disease risk prediction accuracy, particularly for early-onset cases, serving as a valuable complement to traditional clinical risk tools.
Background: The polygenic risk score (PRS) has been perceived as advantageous in predicting the risk of complex diseases compared to other measures. We aimed to systematically evaluate the influence of PRS on disease outcome and to explore its predictive value. Methods: We comprehensively assessed the relationship between PRS and 32 complex diseases in the UK Biobank. We used Cox models to estimate the effects of PRS on the incidence risk. Then, we constructed prediction models to assess the clinical utility of PRS in risk prediction. For 16 diseases, we further compared the disease risk and prediction capability of PRS across early and late-onset cases. Conclusions: As a valuable complement to traditional clinical risk tools, PRS is closely related to disease risk and can further enhance prediction accuracy, especially for early-onset cases, underscoring its potential role in targeted prevention for high-risk groups.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: